Chikungunya Investment Portfolios

Valneva Announces European Green Light for First Chikungunya Vaccine, IXCHIQ® Jul 1, 2024

Valneva Commences Pediatric Trial for Single-Dose Chikungunya Vaccine Jan 11, 2024